The purpose of this project is to calculate a therapeutic activity that assures the limit doses are not exceeded for critical organs in patients undergoing the I-131 MIBG / AZEDRA (Progenics Pharmaceuticals, Tarrytown, NY) therapy for pheochromocytoma and paraganglioma.
Details
Title
Clinical dosimetry tool implementation of I-131 MIBG therapy for pheochromocytoma and paraganglioma
Creator
Franco, Roberto P. : Oregon Health and Science University Pugachev, Andrei : Oregon Health and Science University
Meeting Name
Research Week, Oregon Health and Science University, 2020